| 2024年中报 | 2023年年报 | 2023年中报 | 2022年年报 | 2022年中报 | |
|---|---|---|---|---|---|
| 营业收入(元) | |||||
| 技术服务(元) | 19,966,413.97 | 109,990,100.98 | 57,016,897.87 | 43,958,443.25 | 20,521,590.46 |
| 原料药销售(元) | 57,356,450.10 | 94,165,085.00 | 42,138,392.49 | 82,143,271.59 | 39,213,063.07 |
| 制剂销售(元) | 564,910,164.43 | - | 442,134,981.45 | - | 509,242,386.24 |
| CMO/CDMO(元) | 26,569,288.29 | 30,814,707.17 | 13,902,401.99 | 24,304,513.21 | 6,147,716.98 |
| 化学制剂(元) | - | 880,727,048.62 | - | 1,019,473,556.76 | - |
| 营业成本(元) | |||||
| 技术服务(元) | 2,953,628.96 | 5,276,986.74 | - | 264,886.70 | - |
| 原料药销售(元) | 19,921,762.55 | 25,166,521.57 | - | 19,127,610.74 | - |
| 制剂销售(元) | 106,013,060.50 | - | - | - | - |
| CMO/CDMO(元) | 20,236,761.21 | 19,736,431.80 | - | 15,273,066.85 | - |
| 化学制剂(元) | - | 171,944,126.70 | - | 161,248,874.19 | - |
| 毛利(元) | |||||
| 技术服务(元) | 17,012,785.01 | 104,713,114.24 | - | 43,693,556.55 | - |
| 原料药销售(元) | 37,434,687.55 | 68,998,563.43 | - | 63,015,660.85 | - |
| 制剂销售(元) | 458,897,103.93 | - | - | - | - |
| CMO/CDMO(元) | 6,332,527.08 | 11,078,275.37 | - | 9,031,446.36 | - |
| 化学制剂(元) | - | 708,782,921.92 | - | 858,224,682.57 | - |
| 毛利率(%) | |||||
| 技术服务(%) | 85.21 | 95.20 | - | 99.40 | - |
| 原料药销售(%) | 65.27 | 73.27 | - | 76.71 | - |
| 制剂销售(%) | 81.23 | - | - | - | - |
| CMO/CDMO(%) | 23.83 | 35.95 | - | 37.16 | - |
| 化学制剂(%) | - | 80.48 | - | 84.18 | - |
| 收入构成(%) | |||||
| 技术服务(%) | 2.99 | 9.86 | 10.27 | 3.76 | 3.57 |
| 原料药销售(%) | 8.58 | 8.44 | 7.59 | 7.02 | 6.82 |
| 制剂销售(%) | 84.47 | - | 79.64 | - | 88.54 |
| CMO/CDMO(%) | 3.97 | 2.76 | 2.50 | 2.08 | 1.07 |
| 化学制剂(%) | - | 78.94 | - | 87.14 | - |
| 毛利构成(%) | |||||
| 技术服务(%) | 3.27 | 11.72 | - | 4.49 | - |
| 原料药销售(%) | 7.20 | 7.72 | - | 6.47 | - |
| 制剂销售(%) | 88.30 | - | - | - | - |
| CMO/CDMO(%) | 1.22 | 1.24 | - | 0.93 | - |
| 化学制剂(%) | - | 79.32 | - | 88.12 | - |